Autobio Diagnostics Co

Autobio Diagnostics Co Tangible Book Value per Share

The Tangible Book Value per Share of Autobio Diagnostics Co (603658.SS) as of Oct 16, 2026 is 15.18 CNY. In the previous year, Tangible Book Value per Share was 14.41 CNY — a change of 5.36% (higher).

Tangible Book Value per Share

15.18CNY

YoY

5.36%

Last updated:

Tangible Book Value per Share of Autobio Diagnostics Co is 2025 15.18 CNY. Tangible Book Value per Share of Autobio Diagnostics Co was 2024 14.41 CNY. It decreases by 5.36% higher compared to the previous year.

The Autobio Diagnostics Co Tangible Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tangible Book Value per Share
Date
Tangible Book Value per Share
Jan 1, 2018
2.69 CNY
Jan 1, 2019
3.66 CNY
Jan 1, 2020
10.50 CNY
Jan 1, 2021
11.93 CNY
Jan 1, 2022
12.85 CNY
Jan 1, 2023
14.20 CNY
Jan 1, 2024
14.41 CNY
Jan 1, 2025
15.18 CNY
The Autobio Diagnostics Co Tangible Book Value per Share history
YEARTangible Book Value per ShareYoY
15.18CNY+5.36%
14.41CNY+1.51%
14.20CNY+10.48%
12.85CNY+7.71%
11.93CNY+13.59%
10.50CNY+186.75%
3.66CNY+36.23%
2.69CNY+21.75%
2.21CNY-21.59%
2.82CNY+131.85%
1.21CNY+45.11%
0.84CNY-46.30%
1.56CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Autobio Diagnostics Co Stock analysis

What does Autobio Diagnostics Co do? Autobio Diagnostics Co Ltd, listed on the Shanghai Stock Exchange under ticker 603658.SS, is a healthcare company based in Zhengzhou, China. The company specializes in the research, development, manufacturing, integration, service, and distribution of in vitro diagnostic reagents and instruments. With a workforce of 5,505 employees, Autobio Diagnostics went public on September 1, 2016. Its product portfolio includes immunodiagnostic reagents such as microplate chemiluminescence diagnostic reagents, enzyme-linked immunosorbent assay (ELISA) diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. The company also offers microbiology detection products, including training detection reagents, susceptibility detection reagents, and rapid detection reagents. Device products encompass microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers. Autobio Diagnostics primarily serves domestic markets within China, focusing on providing diagnostic solutions for healthcare applications. The company's headquarters is located in Zhengzhou, Henan Province, and it operates within the healthcare sector, specifically in the health care industry. Its website, https://www.autobio.com.cn/, provides further information on its services and products. Autobio Diagnostics Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Autobio Diagnostics Co stock

Tangible Book Value per Share of Autobio Diagnostics Co is 15.18 CNY in 2025.

Tangible Book Value per Share of Autobio Diagnostics Co changed from 14.41 CNY to 15.18 CNY, representing a 5.36% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Tangible Book Value per Share Autobio Diagnostics Co since 2006 – with annual values, charts, and detailed analysis.

Tangible book value per share excludes intangible assets and goodwill, providing a more conservative measure of per-share net asset value.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Autobio Diagnostics Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Autobio Diagnostics Co